SlideShare a Scribd company logo
1 of 41
   Pharmacists Improving Care  and Reducing Costs  image001 logo
Medication Therapy  Management, LLC ,[object Object],[object Object],[object Object]
Scope of  Medication-Related Problems ,[object Object],[object Object],[object Object],Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc.  2001;41:192 – 9. Institute of Medicine. Report Brief: Preventing Medication Errors. Washington, DC: Institute of Medicine; July 2006. http://www.iom.edu/Object.File/Master/35/943/medication%20errors%20new.pdf.
Medication-Related Problems     $$$$ Increased Costs to the Health Care System $$$$ Increased Costs to Employers $$$$ Increased Insurance  Premiums or Direct Costs   dd_senior_drug_caution images
What Is Medication Therapy Management (MTM)? ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],MPj04223650000[1] understanding-diabetes-ga-2 Business-People asthma_child140
Where Are You Spending Your  Health Care Dollars? Kaiser Family Foundation, 2007. http://www.kff.org/insurance/index.cfm
The Spectrum of  Pharmacist-Provided MTM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MTM Core Elements  Service Model   Core Elements ,[object Object],[object Object]
Components of the MTM Core Elements Service Model   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Medication Therapy Reviews ,[object Object],[object Object],[object Object],[object Object],photo_06_News
What Do Patients Get From Care Aligned With the MTM Core Elements Model? ,[object Object],[object Object]
Examples of MTM Interventions   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Examples of MTM Interventions   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
A Case Example From Our Practice   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
A Case Example From Our Practice
Goals of MTM Services  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MTM Services In Action   ,[object Object],[object Object]
Clinical Outcomes of MTM Minnesota MTM Care Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Isetts BJ.  Evaluating Effectiveness of the Minnesota Medication Therapy Management Care Program.  Final Report. [Submitted December 14, 2007]. Available at: http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs16_140283.pdf
Clinical Outcomes of MTM The Asheville Project - Asthma Improved  Asthma control sustained over  5 years Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc.  2006;46:133 – 47.
Clinical Outcomes of MTM The Asheville Project - Diabetes A1C < 7% Total Cholesterol  < 200 mg/dl LDL < 100 mg/dl Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy  diabetes care program. J Am Pharm Assoc.  2003;43:173 – 84.
 Clinical Outcomes of MTM [customize this slide to meet the needs of your target audience - may include clinical outcomes from  your practice or other specific clinical outcomes of interest to your audience]
Economic Outcomes of MTM Minnesota Medicaid MTM Care Program Decrease  in : ,[object Object],[object Object],[object Object],[object Object],Isetts BJ.  Evaluating Effectiveness of the Minnesota Medication Therapy Management Care Program.  Final Report. [Submitted December 14, 2007]. Available at: http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs16_140283.pdf
Total costs  $9,035   $8,913  $8,802   $7,490 (N = 63) Year 3 Savings Per Patient from  Projected  Costs $6,250 from  Baseline  Costs $1,545 Yr 1 Projected $10,390 Year 3 Projected $13,740 Baseline $9,035 Year 2 Projected $11,948 APhA Foundation Patient Self-Management Program for Diabetes – Economic Impact Baseline, Years 1, 2, and 3 Compared With Projected Costs* Data provided by the APhA Foundation.  *Projected increases based on multiple sources, not according to the ADA. Total medical expenditures incurred by people with diabetes were $13,243 per capita in 2002, compared with $2,560 for people without diabetes.
Economic Outcomes of MTM From Our Practice [ customize this slide to meet the needs of your target audience –include economic outcomes from analysis conducted in your own practice  that may be of interest to your target audience]
[object Object],[object Object],[object Object],[object Object],APhA MTM Digest   Examining the Value of MTM Services
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],APhA MTM Digest  Survey Methods
[object Object],[object Object],[object Object],Overall APhA Survey Findings Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007. J Am Pharm Assoc.  2008;48:354 – 63. Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007. J Am Pharm Assoc. 2008;48:478 –86.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],APhA Survey Findings  of the Payer Perspective on Return on Investment (ROI) images Schommer JC, et al. Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007. J Am Pharm Assoc. 2008;48:478 –86.
APhA Survey Findings of  Health Care Measures/Needs Addressed by MTM Services Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
APhA Survey Findings of Impact of MTM on Future Outcomes Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
Considerations for Providing MTM Services ,[object Object],[object Object],[object Object],[object Object]
Our MTM Service Offering ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[Insert Name of the MTM Practice  (Pharmacy or Pharmacist)] ,[object Object]
Billing, Compensation,  and Reporting   ,[object Object],[object Object],[object Object],[object Object]
Billing, Compensation,  and Reporting   ,[object Object]
Together we can…   ,[object Object],[object Object],[object Object],[object Object]
Contact Information   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Appendix to Slide Set  (use/modify/incorporate into slide set if desired) ,[object Object],[object Object],[object Object],[object Object]
Clinical Outcomes of MTM Asthma Patients Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc.  2006;46:133–47. Link to full text: http://japha.metapress.com/link.asp?id=vr845p3l32384830
Economic Outcomes of MTM Decrease in yearly Rx cost to health plan (N = 7 patients) Rx cost to patient/year  (N = 7 patients) McCarthy RA, Bennett MS, Green CG. Abstract: Medication therapy management services for a non-Medicare population: short-term assessment of economic, clinical, and humanistic outcomes. http://www.glprc.com/Abstracts/rptAbstracts%202006.pdf.

More Related Content

What's hot

DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxAmeena Kadar
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS  & evaluation process in qum.pptxBUILDING BLOCKS  & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptxAmeena Kadar
 
Rational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello editRational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello editCipriano Bello
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemRumana Hameed
 
Drug utilization evaluation(DUE) & Drug utilization review)
Drug utilization evaluation(DUE) & Drug utilization review)Drug utilization evaluation(DUE) & Drug utilization review)
Drug utilization evaluation(DUE) & Drug utilization review)Pooja Anothra
 
Drug induced blood disorders
Drug induced blood disordersDrug induced blood disorders
Drug induced blood disordersAnjumAhamadi1
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy ShaistaSumayya
 
The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicinesTGA Australia
 
Pharmacy &amp; self medication by prof. amrutkar rakesh d.
Pharmacy &amp; self medication by prof. amrutkar rakesh d.Pharmacy &amp; self medication by prof. amrutkar rakesh d.
Pharmacy &amp; self medication by prof. amrutkar rakesh d.RakeshAmrutkar
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology aiswarya thomas
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONaishuanju
 
Medication Adherence , setting up directions ..
Medication Adherence , setting up directions .. Medication Adherence , setting up directions ..
Medication Adherence , setting up directions .. Ahmed Nouri
 
Measurement of outcome v5
Measurement  of outcome v5Measurement  of outcome v5
Measurement of outcome v5aiswarya thomas
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy servicesvelspharmd
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology ABUBAKRANSARI2
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemVineetha Menon
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 

What's hot (20)

DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptx
 
BUILDING BLOCKS & evaluation process in qum.pptx
BUILDING BLOCKS  & evaluation process in qum.pptxBUILDING BLOCKS  & evaluation process in qum.pptx
BUILDING BLOCKS & evaluation process in qum.pptx
 
Rational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello editRational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello edit
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage system
 
Drug utilization evaluation(DUE) & Drug utilization review)
Drug utilization evaluation(DUE) & Drug utilization review)Drug utilization evaluation(DUE) & Drug utilization review)
Drug utilization evaluation(DUE) & Drug utilization review)
 
Drug induced blood disorders
Drug induced blood disordersDrug induced blood disorders
Drug induced blood disorders
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
 
The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicines
 
Pharmacy &amp; self medication by prof. amrutkar rakesh d.
Pharmacy &amp; self medication by prof. amrutkar rakesh d.Pharmacy &amp; self medication by prof. amrutkar rakesh d.
Pharmacy &amp; self medication by prof. amrutkar rakesh d.
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATION
 
Medication Adherence , setting up directions ..
Medication Adherence , setting up directions .. Medication Adherence , setting up directions ..
Medication Adherence , setting up directions ..
 
Measurement of outcome v5
Measurement  of outcome v5Measurement  of outcome v5
Measurement of outcome v5
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage system
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 

Similar to MTM Presentation

Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPM Society
 
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...M. Christopher Roebuck
 
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataMore Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataM. Christopher Roebuck
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Naser Tadvi
 
Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013Rebecca Ruggear
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)TORC
 
C clausura outcomes_strategies_drug_utilization_wright_j
C clausura outcomes_strategies_drug_utilization_wright_jC clausura outcomes_strategies_drug_utilization_wright_j
C clausura outcomes_strategies_drug_utilization_wright_jz15sefap
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...SriramNagarajan16
 
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES gpartha85
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptxarslan8262
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptxVishwasATL
 
Community Pharmacists and Medication Therapy ManagementDownl
Community Pharmacists and Medication Therapy ManagementDownlCommunity Pharmacists and Medication Therapy ManagementDownl
Community Pharmacists and Medication Therapy ManagementDownlLynellBull52
 
Medication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceMedication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceScott Miller
 
John lovelace 2011 03 25 public private p artnerships in health dublin mar...
John lovelace 2011 03 25  public private p artnerships in health   dublin mar...John lovelace 2011 03 25  public private p artnerships in health   dublin mar...
John lovelace 2011 03 25 public private p artnerships in health dublin mar...Investnet
 
Best practices for cardiovascular disease prevention programs t
Best practices for cardiovascular disease prevention programs tBest practices for cardiovascular disease prevention programs t
Best practices for cardiovascular disease prevention programs tssuser454af01
 
media release mediscor mmr
media release mediscor mmr media release mediscor mmr
media release mediscor mmr Bukmarker
 

Similar to MTM Presentation (20)

Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
 
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataMore Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance
 
ISPOR
ISPORISPOR
ISPOR
 
Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)
 
C clausura outcomes_strategies_drug_utilization_wright_j
C clausura outcomes_strategies_drug_utilization_wright_jC clausura outcomes_strategies_drug_utilization_wright_j
C clausura outcomes_strategies_drug_utilization_wright_j
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...
 
teamLift-ppt-v1
teamLift-ppt-v1teamLift-ppt-v1
teamLift-ppt-v1
 
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH DIABETES
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptx
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptx
 
Community Pharmacists and Medication Therapy ManagementDownl
Community Pharmacists and Medication Therapy ManagementDownlCommunity Pharmacists and Medication Therapy ManagementDownl
Community Pharmacists and Medication Therapy ManagementDownl
 
MTM
MTMMTM
MTM
 
Medication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceMedication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic Alliance
 
John lovelace 2011 03 25 public private p artnerships in health dublin mar...
John lovelace 2011 03 25  public private p artnerships in health   dublin mar...John lovelace 2011 03 25  public private p artnerships in health   dublin mar...
John lovelace 2011 03 25 public private p artnerships in health dublin mar...
 
Best practices for cardiovascular disease prevention programs t
Best practices for cardiovascular disease prevention programs tBest practices for cardiovascular disease prevention programs t
Best practices for cardiovascular disease prevention programs t
 
media release mediscor mmr
media release mediscor mmr media release mediscor mmr
media release mediscor mmr
 
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
 

Recently uploaded

High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 

Recently uploaded (20)

High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 

MTM Presentation

  • 1. Pharmacists Improving Care and Reducing Costs image001 logo
  • 2.
  • 3.
  • 4. Medication-Related Problems $$$$ Increased Costs to the Health Care System $$$$ Increased Costs to Employers $$$$ Increased Insurance Premiums or Direct Costs dd_senior_drug_caution images
  • 5.
  • 6.
  • 7. Where Are You Spending Your Health Care Dollars? Kaiser Family Foundation, 2007. http://www.kff.org/insurance/index.cfm
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. A Case Example From Our Practice
  • 17.
  • 18.
  • 19.
  • 20. Clinical Outcomes of MTM The Asheville Project - Asthma Improved Asthma control sustained over 5 years Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133 – 47.
  • 21. Clinical Outcomes of MTM The Asheville Project - Diabetes A1C < 7% Total Cholesterol < 200 mg/dl LDL < 100 mg/dl Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173 – 84.
  • 22. Clinical Outcomes of MTM [customize this slide to meet the needs of your target audience - may include clinical outcomes from your practice or other specific clinical outcomes of interest to your audience]
  • 23.
  • 24. Total costs $9,035 $8,913 $8,802 $7,490 (N = 63) Year 3 Savings Per Patient from Projected Costs $6,250 from Baseline Costs $1,545 Yr 1 Projected $10,390 Year 3 Projected $13,740 Baseline $9,035 Year 2 Projected $11,948 APhA Foundation Patient Self-Management Program for Diabetes – Economic Impact Baseline, Years 1, 2, and 3 Compared With Projected Costs* Data provided by the APhA Foundation. *Projected increases based on multiple sources, not according to the ADA. Total medical expenditures incurred by people with diabetes were $13,243 per capita in 2002, compared with $2,560 for people without diabetes.
  • 25. Economic Outcomes of MTM From Our Practice [ customize this slide to meet the needs of your target audience –include economic outcomes from analysis conducted in your own practice that may be of interest to your target audience]
  • 26.
  • 27.
  • 28.
  • 29.
  • 30. APhA Survey Findings of Health Care Measures/Needs Addressed by MTM Services Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
  • 31. APhA Survey Findings of Impact of MTM on Future Outcomes Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40. Clinical Outcomes of MTM Asthma Patients Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133–47. Link to full text: http://japha.metapress.com/link.asp?id=vr845p3l32384830
  • 41. Economic Outcomes of MTM Decrease in yearly Rx cost to health plan (N = 7 patients) Rx cost to patient/year (N = 7 patients) McCarthy RA, Bennett MS, Green CG. Abstract: Medication therapy management services for a non-Medicare population: short-term assessment of economic, clinical, and humanistic outcomes. http://www.glprc.com/Abstracts/rptAbstracts%202006.pdf.